Community Health Systems stock
CYHNYSECommunity Health Systems, Inc., HealthcareISIN US2036681086
34Score 34 out of 100, Weak
Price and trend
29 / 100
Price history
−35% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 26% below it.
Since April 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Sharply down: the price has fallen very quickly lately (RSI 30).
The price is 43% below its 52-week high. Largest decline in 20 years: 97% (June 2015 to August 2019).
Chart figures for advanced users
- SMA 50$2.74
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$2.99
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)30
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$2.05
- The lowest closing price of the last twelve months.
- Resistance$3.90
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Community Health Systems, Inc. belongs to the Medical (Care Facilities) industry (United States) and, with a market value of $311.67M, is number 54 of 56 companies in its industry on MEQIRI.
- For fiscal 2026, analysts expect on average revenue of $11.36B (down 9%) and adjusted earnings per share of −$1.30.
- MEQIRI Score 34 out of 100 (Weak): rank 645 of 714 in Healthcare, median 53.
Show more
- The P/E is 8.4 (Medical (Care Facilities) median 19.4, own median of recent years 4.5).
- Our model puts fair value at $5.12, with the price 55% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
None of our strength checks applies.
Weaknesses
- Negative free cash flowFree cash flow −$122M over the last 12 months.Fundamentals 30
- Interest barely coveredOperating profit covers interest only 1.8 times.Stability 35
- DilutionShare count up 16% since 2020.Capital allocation 34
Its standout strength is valuation, while growth and momentum hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk high
How well MEQIRI warnsOne of the 30% with the highest crash risk among smaller stocks.
From 2016 to 2025, 36 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- weak fundamentals
- price far below its 52-week high
- weak momentum
What lowers it
- low growth grade (crashed less often in the backtest)
- price not overheated over the past year
Valuation
Valuation signal
Possible value trapClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $3.66 and expensive above $8.54 (uncertainty high, based on the price swings of the past year).
Possible value trap: looks cheap, but score below 50, high risk, weak growth, weak balance sheet.
Valuation metrics
From earnings times the industry P/E (19.4) alone; there are no viable cash flows for the cash-flow model.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue fell 7.8% on the twelve months before. Revenue has grown solidly since 2006, at about 6% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 12%, operating 12%, net 4%.
Debt & balance sheet
latest quarterDebt is elevated. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 17 Feb 2027in 96 days
- Last reported
- 28 Oct 2026EPS reported −$0.48 (expected −$0.29)below expectations
Analyst estimates
Analysts have cut their 2027 earnings estimate by 102.3% since 15 Oct 2026. Falling estimates often precede bad news.
- Earnings per share
- −$1.30−15.0%
- Revenue
- $11.36B−0.7%
- Earnings per share
- −$0.93−102.3%
- Revenue
- $11.33B−1.7%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook lowered
Share price after the results: −9.8%Community Health Systems cut its full-year 2026 outlook: revenue now expected at 11.3 to 11.5 billion dollars and adjusted EBITDA only 1.225 to 1.275 billion dollars, about 6.5% below the prior midpoint, while operating cash flow guidance was also lowered to 100 to 300 million dollars.
“Net revenue is now expected to be $11.3 billion-$11.5 billion and adjusted EBITDA range is now $1.225 billion-$1.275 billion, or a 6.5% reduction at the midpoint. We have also reduced the cash flow from operations guidance to $100 million-$300 million, primarily reflecting the lower EBITDA.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 29 Oct 2026 (fiscal Q3 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases in the last 6 months. One insider sold, $118,400 in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
- Jennings William NorrisSale
25 Aug 2026, Board
- Shares
- 40,000
- Price
- $2.96
- Value
- $118,400
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Community Health Systems
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
714 rated companies in Healthcare
- This company
- 34
- Sector median
- 53
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Medical (Care Facilities)
The next larger and next smaller companies by market value
- GMR SolutionsGMRS $635.3M57
- Strata Critical MedicalSRTA $536.81M47
- Starling OncologySTLN $419.93M26
- M1 KlinikenM12.DE $402.19M74
- AunaAUNA $347.12M43
- Viemed HealthcareVMD $345.96M65
- MediclinMED.DE $285.41M61
- LIMES SchlossklinikenLIK.DE $190.63M73
ETFs that hold Community Health Systems
Held by 3 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares Ageing Population UCITS ETF2B77 | 0.03% | 0.40% | €807M |
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.01% | 0.30% | €2.17B |
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.01% | 0.30% | €4.22B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 20 Feb 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.